ALGS vs WMB · rev $3.6M vs P/E 31, rev $11.95B
Aligos Therapeutics Inc (ALGS) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported WMB revenue for 2025-12-31 was $11.95B. Net income was $2.62B. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
ALGS currently screens at market cap $44.1M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the ALGS and WMB stock pages for the full models.
Not investment advice.